The team showed that the reprogramming process for generating iPS cells (i.e., cells than can be 'coaxed' to a variety of cellular types for regenerate drug) is associated with inherent DNA damage.
The team showed that the reprogramming process for generating iPS cells (i.e., cells that can then be 'coaxed' to become a variety of cell types for use in regenerative medicine) is associated with inherent DNA damage.